Literature DB >> 23247066

A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.

Tiffany Hink1, Carey-Ann D Burnham, Erik R Dubberke.   

Abstract

With the increasing prevalence of Clostridium difficile infection among hospitalized patients, a clear understanding of C. difficile epidemiology is needed to evaluate current prevention policies, and to create new and effective policies. To determine the epidemiology of C. difficile, the most sensitive methods for detection of C. difficile are required. The purpose of this study was to systematically assess multiple methods to determine the most sensitive method to recover C. difficile from stool and rectal swabs. Stool samples from healthy asymptomatic individuals that were collected and confirmed to be culture negative for C. difficile were spiked with known concentrations of C. difficile ranging from 10(4) CFU of C. difficile per ml of stool to 10 CFU per ml. Two sets of experiments (A and B) were performed and each involved multiple combinations of untreated and treated stool/rectal swab specimens and selective and non-selective broth and agar. Overall, recovery of C. difficile was increased with the use of an initial broth enrichment followed by plating to solid medium. The most sensitive method of C. difficile detection for both stools and swab specimens was heat shock prior to inoculation of cycloserine-cefoxitin mannitol broth with taurocholate lysozyme cysteine (CCMB, Anaerobe Systems, Morgan Hill, CA) followed by isolation from pre-reduced TSA II with 5% sheep blood (BAP, BBL BD and Co., Sparks, MD). Identifying the most sensitive method of recovery will allow for further study of asymptomatic C. difficile carriers and their role in the epidemiology of C. difficile.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23247066      PMCID: PMC4146438          DOI: 10.1016/j.anaerobe.2012.12.001

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  15 in total

1.  Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery of Clostridium difficile.

Authors:  M H Wilcox; W N Fawley; P Parnell
Journal:  J Hosp Infect       Date:  2000-01       Impact factor: 3.926

2.  Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions.

Authors:  Luis G Arroyo; Joyce Rousseau; Barbara M Willey; Don E Low; Henry Staempfli; Allison McGeer; J Scott Weese
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients.

Authors:  D Z Bliss; S Johnson; C R Clabots; K Savik; D N Gerding
Journal:  Diagn Microbiol Infect Dis       Date:  1997-09       Impact factor: 2.803

4.  Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.

Authors:  Michelle M Riggs; Ajay K Sethi; Trina F Zabarsky; Elizabeth C Eckstein; Robin L P Jump; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2007-09-04       Impact factor: 9.079

5.  Comparison of five cultural procedures for isolation of Clostridium difficile from stools.

Authors:  L M Marler; J A Siders; L C Wolters; Y Pettigrew; B L Skitt; S D Allen
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

6.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

7.  Detection and enumeration of Clostridium difficile spores in retail beef and pork.

Authors:  J Scott Weese; Brent P Avery; J Rousseau; Richard J Reid-Smith
Journal:  Appl Environ Microbiol       Date:  2009-06-12       Impact factor: 4.792

8.  Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; Rosalind M Harding; Lily O'Connor; David Griffiths; Ali Vaughan; John Finney; Mark H Wilcox; Derrick W Crook; Tim E A Peto
Journal:  PLoS Med       Date:  2012-02-07       Impact factor: 11.069

9.  Clostridium difficile in retail meat products, USA, 2007.

Authors:  J Glenn Songer; Hien T Trinh; George E Killgore; Angela D Thompson; L Clifford McDonald; Brandi M Limbago
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

10.  Clostridium difficile in retail ground meat, Canada.

Authors:  Alexander Rodriguez-Palacios; Henry R Staempfli; Todd Duffield; J Scott Weese
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more
  27 in total

1.  Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strains.

Authors:  Mark D Gonzalez; Meghan A Wallace; Tiffany Hink; Erik R Dubberke; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

2.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

3.  Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.

Authors:  Alison L Galdys; Jemma S Nelson; Kathleen A Shutt; Jessica L Schlackman; Diana L Pakstis; A William Pasculle; Jane W Marsh; Lee H Harrison; Scott R Curry
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

4.  Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.

Authors:  Carolina Pantuzza Ramos; Emily Oliveira Lopes; Amanda Nádia Diniz; Francisco Carlos Faria Lobato; Eduardo Garcia Vilela; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2020-05-04       Impact factor: 2.476

5.  Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.

Authors:  Jennie H Kwon; Kimberly A Reske; Tiffany Hink; C A Burnham; Erik R Dubberke
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

Review 6.  Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.

Authors:  Shuyi Chen; Huawei Gu; Chunli Sun; Haiying Wang; Jufang Wang
Journal:  Infection       Date:  2016-09-06       Impact factor: 3.553

Review 7.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

8.  Clostridium difficile Colonization of Nursing Home Residents.

Authors:  Mary-Claire Roghmann; Liana R Andronescu; Emily M Stucke; J Kristie Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2017-08-22       Impact factor: 3.254

9.  Impact of an electronic hard-stop clinical decision support tool to limit repeat Clostridioides difficile toxin enzyme immunoassay testing on test utilization.

Authors:  Jennie H Kwon; Kimberly A Reske; Tiffany Hink; Ronald Jackups; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2019-10-24       Impact factor: 3.254

10.  An Evaluation of Food as a Potential Source for Clostridium difficile Acquisition in Hospitalized Patients.

Authors:  Jennie H Kwon; Cristina Lanzas; Kimberly A Reske; Tiffany Hink; Sondra M Seiler; Kerry M Bommarito; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2016-10-03       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.